RxDoctor Payments Data

Thomas Thompson, MD

Family Medicine · Cary, NCNPI 1033370861

Payments from drug & device makers

$1,415in general payments, 2019–2025

Across 76 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$248
  • Novo Nordisk$224
  • AbbVie$187
  • Gilead$186
  • GSK$104
  • Exact Sciences$59
  • plus $407 from 13 others

What the payments were for

  • Food & beverage$1,415100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,415 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$92,604
Medicare patients
154
Services billed
1,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban73$88,199
JardianceEmpagliflozin63$73,269
MounjaroTirzepatide35$41,230
XareltoRivaroxaban28$35,392
OzempicSemaglutide15$28,076
Nurtec OdtRimegepant Sulfate13$25,555
TradjentaLinagliptin15$23,369
Tresiba Flextouch U-200Insulin Degludec41$21,849
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog29$18,278
Humalog Kwikpen U-200Insulin Lispro12$10,437
AbrysvoRsv Vacc, Pref A And Pref B/Pf18$5,809
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,591
Atorvastatin Calcium340$3,329
Valsartan132$3,049
Nano 2nd Gen Pen NeedlePen Needle, Diabetic18$2,364

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt, Abrysvo$38$119,563104 claims
Lilly USA, LLCMounjaro$248$41,23035 claims
Johnson & JohnsonXarelto$28$35,39228 claims
Novo NordiskOzempic$224$28,07615 claims
GSKShingrix$104$4,59121 claims
AbbVieSynthroid$187$94523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Cary

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →